Related Experiment Videos

Rational Therapy of Urinary Tract Infections in Children in Croatia

Danko Milošević1,2, Danica Batinić3, Vladimir Trkulja1,2

  • 1Zagreb University Hospital Center, University of Zagreb School of Medicine, Zagreb, Croatia

Acta Clinica Croatica
|October 19, 2017
PubMed

Insights

Antimicrobial resistance is rising globally, necessitating careful antibiotic selection for urinary tract infections (UTIs). Optimal treatment balances efficacy, patient safety, and cost-effectiveness, especially in children.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Pediatrics

Background:

  • Increasing global resistance to chemotherapeutics for urinary tract infections (UTIs) poses a significant clinical challenge.
  • Bacterial resistance patterns in Croatia and neighboring regions highlight the need for optimized antibiotic selection.
  • Pediatric UTIs require special consideration due to age-related risks of systemic reactions and renal scarring.

Purpose of the Study:

  • To emphasize the critical need for optimal antibiotic selection in managing urinary tract infections.
  • To highlight the importance of considering local resistance patterns and clinical experience.
  • To underscore the financial considerations and cost-benefit analysis in antimicrobial therapy.

Main Methods:

  • Review of clinical experiences and current bacterial resistance data.
  • Analysis of treatment strategies for pediatric urinary tract infections.
  • Evaluation of financial aspects and cost-effectiveness in antimicrobial therapy.

Main Results:

  • Optimal antibiotic selection is crucial given rising antimicrobial resistance.
  • Early switch from parenteral to oral antibiotics is recommended when feasible.
  • Financial considerations must align with the principle of 'primum non nocere' (first, do no harm).

Conclusions:

  • Judicious antibiotic selection is paramount for effective UTI treatment amidst growing resistance.
  • Pediatric UTI management requires a tailored approach prioritizing safety and minimizing long-term complications.
  • Antimicrobial therapy decisions must integrate clinical efficacy, safety, local resistance data, and economic factors.

Related Concept Videos